MiR-143-3p inhibits colorectal cancer metastases by targeting ITGA6 and ASAP3.

MiR-143-3p inhibits colorectal cancer metastases by targeting ITGA6 and ASAP3.

Cancer Sci. 2018 Dec 11;:

Authors: Guo L, Fu J, Sun S, Zhu M, Zhang L, Niu H, Chen Z, Zhang Y, Guo L, Wang S

Abstract
MicroRNAs, which regulate messenger RNAs, operate through a variety of signaling pathways to participate in the development of colorectal cancer (CRC). In this study, we found that miR-143-3p expression was significantly lower in both CRC and liver metastatic CRC tissues from liver compared with normal colonic tissues. Functional assays showed that miR-143-3p inhibited CRC cell invasion and migration in vitro. Using a bioinformatics approach, we identified miR-143-3p target mRNAs. Among the candidate targets, only the expression of integrin alpha 6 (ITGA6) and ArfGAP with the SH3 domain and ankyrin repeat and PH domain 3 (ASAP3) were significantly reduced by miR-143-3p mimics as examined by western blot, and the metastasis potential of CRC cells was attenuated by endogenous ITGA6 and ASAP3 knockdown, determined by migration and invasion assays. ITGA6 and ASAP3 were upregulated in CRC tissues compared to normal tissues. Analysis of the relationship between clinicopathological features and ITGA6/ASAP3 protein expression in 200 patients with CRC showed a significant difference in positive ITGA6 expression between the early stage (I+II) and the advanced stage (III+IV), and ASAP3 expression levels positively correlated with metastasis in the lymph nodes. These results indicate that miR-143-3p acts as an anti-oncogene via downregulating ITGA6/ASAP3 protein expression and may offer new insight into potential therapeutic targets for CRC. This article is protected by copyright. All rights reserved.

PMID: 30536996 [PubMed - as supplied by publisher]

from PubMed via alexandrossfakianakis on Inoreader https://ift.tt/2rx7hvn